EV/EBITDA:
-15.60+0.52(+3.23%)Summary
- As of today (June 17, 2025), MLTX EV/EBITDA is -15.60, with a rise of +0.52 (+3.23%) during the most recent trading session on June 16, 2025.
- Over the past year, MLTX EV/EBITDA has increased by +18.36 (+54.06%).
- MLTX EV/EBITDA is now -514.17% below its all-time high of -2.54.
Performance
MLTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
MLTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +3.2% | -3.2% | -3.0% |
| 1 m1 month | -15.3% | +15.3% | +14.0% |
| 3 m3 months | +7.1% | +11.0% | +10.9% |
| 6 m6 months | +46.8% | -20.5% | -23.8% |
| ytdytd | +31.7% | -21.9% | -20.8% |
| 1 y1 year | +54.1% | +22.0% | +6.8% |
| 5 y5 years | - | - | - |
MLTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -13.53 | -15.3% | -18.80 | +17.0% |
| 3 m | 3-month | -11.66 | -33.8% | -18.80 | +17.0% |
| 6 m | 6-month | -11.66 | -33.8% | -29.31 | +46.8% |
| 1 y | 1-year | -11.66 | -33.8% | -40.25 | +61.2% |
| 3 y | 3-year | -2.54 | -514.2% | -63.12 | +75.3% |
| 5 y | 5-year | -2.54 | -514.2% | -63.12 | +75.3% |
| alltime | all time | -2.54 | -514.2% | -63.12 | +75.3% |
MLTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -15.60(-31.7%) |
| 2024 | -22.84(-61.4%) |
| Date | Value |
|---|---|
| 2023 | -59.22(+895.3%) |
| 2022 | -5.95 |
FAQ
- What is MoonLake Immunotherapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
- What is MLTX EV/EBITDA year-to-date change?
- What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
What is MoonLake Immunotherapeutics EV/EBITDA?
The current EV/EBITDA of MLTX is -15.60
What is the all time high EV/EBITDA for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high EV/EBITDA is -2.54
What is MLTX EV/EBITDA year-to-date change?
MoonLake Immunotherapeutics EV/EBITDA has changed by +7.24 (+31.70%) since the beginning of the year
What is MoonLake Immunotherapeutics EV/EBITDA year-on-year change?
Over the past year, MLTX EV/EBITDA has changed by +18.36 (+54.06%)